| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 422.311 | 467.565 | 405.467 | 360.092 | 373.886 | 115.739 | 322.246 | 194.551 | 147.207 | 78.947 |
| Total Income - EUR | 429.704 | 478.872 | 413.041 | 453.848 | 373.999 | 127.705 | 330.181 | 195.328 | 148.624 | 79.650 |
| Total Expenses - EUR | 414.783 | 421.906 | 374.467 | 366.374 | 281.176 | 142.631 | 152.039 | 205.935 | 153.863 | 86.079 |
| Gross Profit/Loss - EUR | 14.922 | 56.967 | 38.574 | 87.474 | 92.824 | -14.926 | 178.142 | -10.606 | -5.240 | -6.429 |
| Net Profit/Loss - EUR | 12.282 | 47.009 | 34.514 | 82.936 | 89.084 | -16.000 | 175.261 | -12.196 | -6.695 | -8.771 |
| Employees | 9 | 10 | 10 | 10 | 10 | 8 | 8 | 7 | 6 | 3 |
Check the financial reports for the company - Mednet Research Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 75.515 | 78.053 | 93.144 | 27.941 | 21.508 | 17.256 | 13.034 | 8.805 | 5.796 | 0 |
| Current Assets | 87.305 | 113.719 | 106.393 | 114.425 | 112.339 | 52.701 | 181.082 | 101.532 | 38.463 | 14.715 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 19.480 | 38.978 | 14.160 | 8.920 | 97.506 | 48.229 | 115.788 | 47.463 | 5.353 | 791 |
| Cash | 67.825 | 74.741 | 92.233 | 105.505 | 14.833 | 4.472 | 65.294 | 54.069 | 33.110 | 13.924 |
| Shareholders Funds | 8.455 | 48.346 | 62.225 | 112.350 | 98.335 | 45.736 | 161.541 | 91.063 | 39.483 | 9.514 |
| Social Capital | 56 | 56 | 55 | 54 | 53 | 52 | 51 | 51 | 51 | 50 |
| Debts | 154.366 | 143.427 | 137.312 | 30.015 | 35.511 | 24.221 | 32.575 | 19.275 | 4.775 | 5.200 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7320 - 7320" | |||||||||
| CAEN Financial Year |
7320
|
|||||||||
Comments - Mednet Research Srl